Newsroom
Category
May 18, 2020
Cancer biologists at the Mays Cancer Center, home to UT Health San Antonio MD Anderson, have identified important drivers that enable tumors to change their behavior and evade anticancer therapies. By studying tumors in cell lines, mice and human samples, the team documented genetic signals that promote the conversion of cancer cells from one stage […]
May 15, 2020
UT Health San Antonio’s May commencements are occurring virtually this month in response to the COVID-19 pandemic. Nearly 700 students have completed requirements for entry into the health care and research workforce as physicians, nurses, dentists, health professionals and biomedical scientists. Many will remain in Texas to practice. The university’s Long School of Medicine will […]
May 13, 2020
Media contact: Rosanne Fohn, (210) 567-3026, fohn@uthscsa.edu SAN ANTONIO (May 11, 2020) — The COVID-19 Infectious Disease team at UT Health San Antonio and University Health System is beginning the second stage of the remdesivir clinical trial, which is being sponsored by the National Institute of Allergy and Infectious Diseases, NIAID. This second phase of […]
May 12, 2020
Stroke experts at UT Health San Antonio are urging area residents not to let anything – including fear of the coronavirus – stop them from calling 911 if they have face, arm or speech symptoms. “Patients should never hesitate to call an ambulance if they have signs of a stroke,” said Justin Mascitelli, M.D., assistant […]
May 4, 2020
Do thinking and walking go hand in hand in determining the health course of senior adults? A study published by UT Health San Antonio researchers found that, indeed, the two functions often parallel each other in determining a person’s health trajectory. The researchers analyzed data from 370 participants in the San Antonio Longitudinal Study of […]
May 2, 2020
SAN ANTONIO (May 1, 2020) — The FDA on May 1 gave emergency authorization to a new anti-viral drug to treat patients with COVID-19. The announcement was made during an afternoon news conference by President Trump. It comes two days after the National Institute of Allergy and Infectious Diseases (NIAID) released preliminary results of a […]
